Revelation Biosciences Inc is a clinical-stage life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of disease. It has several product candidates in development. REVTx-99, the lead therapeutic candidate, is an intranasal immunomodulator to ... Revelation Biosciences Inc is a clinical-stage life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of disease. It has several product candidates in development. REVTx-99, the lead therapeutic candidate, is an intranasal immunomodulator to prevent or treat infections caused by various respiratory viruses such as SARS-CoV-2, including its variants, influenza A and B, parainfluenza, rhinovirus, and RSV. REVTx-99 is also being developed for other indications such as: allergic rhinitis and chronic nasal congestion. REVTx-200 is an intranasal immunomodulator adjunct to be used in combination with an intramuscular vaccination for more complete immunity. REVTx-200 is based on the same technology used in REVTx-99. Show more
Revelation Biosciences, Inc. (NASDAQ: REVB) (the βCompanyβ or βRevelationβ), a clinical-stage life sciences company that is focused on harnessing the power of trained immunity for the prevention...
Revelation Biosciences Inc. (NASDAQ: REVB) (the βCompanyβ or βRevelationβ), a life sciences company that is focused on harnessing the power of trained immunity for the prevention and treatment of...
Revelation Biosciences, Inc. (NASDAQ: REVB) (the βCompanyβ or βRevelationβ), a clinical-stage biopharmaceutical company focused on harnessing the power of trained immunity for the prevention and...
-Gemini administration induced statistically significant, dose dependent changes in key biomarkers of activity- -Gemini was safe and well tolerated at pharmacologically active doses- -Phase 1...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0753 | -8.70117864571 | 0.8654 | 0.875 | 0.7532 | 64544 | 0.83104926 | CS |
4 | -0.0699 | -8.12790697674 | 0.86 | 0.98 | 0.702 | 230520 | 0.83039059 | CS |
12 | -1.0699 | -57.5215053763 | 1.86 | 3.5 | 0.702 | 1749212 | 1.93549795 | CS |
26 | -1.9099 | -70.737037037 | 2.7 | 3.8 | 0.702 | 1140609 | 2.05309883 | CS |
52 | -19.5529 | -96.1161087352 | 20.343 | 25.26 | 0.702 | 710665 | 3.26754457 | CS |
156 | -8798.2099 | -99.9910205705 | 8799 | 10237.5 | 0.702 | 1277425 | 823.80805182 | CS |
260 | -8798.2099 | -99.9910205705 | 8799 | 10237.5 | 0.702 | 1277425 | 823.80805182 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.